Publications by authors named "Lorraine McNeil"
Article Synopsis
- Multiple Sclerosis (MS) causes inflammation that leads to damage in the brain and spinal cord, resulting in disability, and current treatment options for remyelination are limited.
- Researchers have developed genetically edited oligodendrocyte progenitor cells (OPCs) that can better migrate and repair damage in chronic MS lesions, in response to obstacles that normally hinder their performance.
- In rodent models, these edited OPCs showed improved remyelination capabilities regardless of the age of the host, suggesting potential new therapeutic strategies for treating progressive MS in humans.
